SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has ...
Please provide your email address to receive an email when new articles are posted on . The FDA granted de novo classification to the Fysx ocular pressure adjusting pump for patients with ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced U.S. Food and Drug Administration (FDA) clearance of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback